Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
September 07 2023 - 5:04AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES
EXCHANGE ACT OF 1934
For
the month of September 2023
Commission
File Number 001-40517
BON
NATURAL LIFE LIMITED
(Translation
of registrant’s name into English)
25F,
Rongcheng Yungu, Keji 3rd Road
Xi’an
Hi-Tech Zone, Xi’an, China
People’s
Republic of China
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☒ Form
40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Note:
Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report
to security holders.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Note:
Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that
the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated,
domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on
which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to
be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the
subject of a Form 6-K submission or other Commission filing on EDGAR.
On
June 30, 2023, the Company received a letter from Nasdaq Stock Market, LLC (“Nasdaq”), notifying the Company that it no longer
complies with Nasdaq’s majority independent board and independent audit, compensation, and nominating committee requirements as
set forth in Listing Rule 5605. On August 14, 2023, the Company submitted a plan to regain compliance to Nasdaq. By letter dated August
21, 2023, Nasdaq gave the Company an extension of up until October 16, 2023 to regain compliance with Nasdaq’s independent board
and committee requirements.
As
disclosed in its Report on Form 6-K filed with the SEC on August 4, 2023, the Company appointed Jianjun Gao, Ph.D. as a new independent
director on August 2, 2023. The Company has identified and is in the process of retaining two additional independent directors to serve
on its board, and it intends to have fully restored a majority independent board within the near future.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
Date: September 7, 2023 |
Bon Natural Life Limited |
|
|
|
|
By: |
/s/ Yongwei
Hu |
|
|
Yongwei Hu |
|
|
Chairman and Chief Executive Officer |
Bon Natural Life (NASDAQ:BON)
Historical Stock Chart
From Dec 2024 to Jan 2025
Bon Natural Life (NASDAQ:BON)
Historical Stock Chart
From Jan 2024 to Jan 2025